These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29124494)

  • 1. Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population.
    O'Neill SC; Evans C; Hamilton RJ; Peshkin BN; Isaacs C; Friedman S; Tercyak KP
    Fam Cancer; 2018 Jul; 17(3):351-360. PubMed ID: 29124494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
    Gill G; Beard C; Storey K; Taylor S; Sexton A
    Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Second-Class Status?" Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome.
    Suttman A; Pilarski R; Agnese DM; Senter L
    J Genet Couns; 2018 Aug; 27(4):885-893. PubMed ID: 29404823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet support needs and distress among women with a BRCA1/2 mutation.
    Farrelly A; White V; Meiser B; Jefford M; Young MA; Ieropoli S; Winship I; Duffy J
    Fam Cancer; 2013 Sep; 12(3):509-18. PubMed ID: 23264090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic cancer risk assessment: A screenshot of the psychosocial profile of women at risk for hereditary breast and ovarian cancer syndrome.
    Campacci N; de Campos Reis Galvão H; Garcia LF; Ribeiro PC; Grasel RS; Goldim JR; Ashton-Prolla P; Palmero EI
    Psychooncology; 2020 Apr; 29(4):681-687. PubMed ID: 31984583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.
    Evans C; Hamilton RJ; Tercyak KP; Peshkin BN; Rabemananjara K; Isaacs C; O'Neill SC
    Healthcare (Basel); 2016 Jun; 4(3):. PubMed ID: 27417623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
    Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
    Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information needs and coping styles of primary family caregivers of women following breast cancer surgery.
    Nikoletti S; Kristjanson LJ; Tataryn D; McPhee I; Burt L
    Oncol Nurs Forum; 2003; 30(6):987-96. PubMed ID: 14603356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initial development of an instrument to assess the psychosocial needs and unmet needs of young people who have a parent with cancer: piloting the offspring cancer needs instrument (OCNI).
    Patterson P; Pearce A; Slawitschka E
    Support Care Cancer; 2011 Aug; 19(8):1165-74. PubMed ID: 20574665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
    Werner-Lin A; Ratner R; Hoskins LM; Lieber C
    J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of an instrument to assess the unmet needs of young people who have a sibling with cancer: piloting the Sibling Cancer Needs Instrument (SCNI).
    Patterson P; Millar B; Visser A
    J Pediatr Oncol Nurs; 2011; 28(1):16-26. PubMed ID: 20739587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological Distress and Coping Ability of Women at High Risk of Hereditary Breast and Ovarian Cancer before Undergoing Genetic Counseling-An Exploratory Study from Germany.
    Vajen B; Rosset M; Wallaschek H; Baumann E; Schlegelberger B
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33921890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trial.
    Kwiatkowski F; Dessenne P; Laquet C; Daures JP; Gay-Bellile M; Bignon YJ
    Trials; 2016 Oct; 17(1):509. PubMed ID: 27769293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.